Telomir Pharmaceuticals Financial Ratios for Analysis 2022-2023 | TELO

Fifteen years of historical annual and quarterly financial ratios and margins for Telomir Pharmaceuticals (TELO).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
0.330.05
--
0.03-
--
--
--
--
--
--
--
--
--
--
-380.1991.13
-380.1991.13
-273.83-1,752.82
-380.1991.13
0.12-0.03
-0.13-0.02
-0.13-0.02

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-31
1.743.937.200.33----
--------
---0.03----
--------
--------
--------
--------
--------
--------
--------
--------
--------
--------
-1,355.14-92.44-207.34-271.30----
-1,355.14-92.44-207.34-271.30----
-574.93-68.94-178.54-195.40----
-1,355.14-92.44-207.34-271.30----
0.010.050.100.12----
-0.15-0.12-0.070.00-0.10-0.03-0.030.00
-0.15-0.12-0.07--0.10-0.03-0.03-